Vertex Pharmaceuticals Inc / Ma

Bank of New York Mellon Corp VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

1,527,586

Value ($000)

692,546

Weight

0.1%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	692,546	0.1%	1,527,586	12/31/2025
2025 Q3	11/3/2025	614,547	0.1%	1,569,165	9/30/2025
2025 Q2	8/5/2025	712,531	0.1%	1,600,473	6/30/2025
2025 Q1	4/29/2025	829,849	0.2%	1,711,665	3/31/2025
2024 Q4	2/4/2025	708,436	0.1%	1,759,216	12/31/2024
2024 Q3	11/12/2024	830,971	0.2%	1,786,728	9/30/2024
2024 Q2	7/25/2024	861,343	0.2%	1,837,650	6/30/2024
2024 Q1	4/25/2024	783,405	0.2%	1,874,129	3/31/2024
2023 Q4	1/29/2024	804,417	0.2%	1,976,988	12/31/2023
2023 Q3	10/24/2023	700,312	0.2%	2,013,896	9/30/2023
2023 Q2	8/3/2023	702,925	0.1%	1,997,457	6/30/2023
2023 Q1	5/9/2023	642,082	0.1%	2,037,904	3/31/2023
2022 Q4	2/14/2023	601,326	0.1%	2,082,299	12/31/2022
2022 Q3	11/14/2022	602,669	0.1%	2,081,470	9/30/2022
2022 Q2	8/15/2022	591,280	0.1%	2,098,301	6/30/2022
2022 Q1	5/11/2022	522,687	0.1%	2,002,865	3/31/2022
2021 Q4	2/11/2022	452,993	0.1%	2,062,806	12/31/2021
2021 Q3	11/18/2021	378,884	0.1%	2,088,788	9/30/2021
2021 Q2	8/11/2021	426,390	0.1%	2,114,718	6/30/2021
2021 Q1	5/13/2021	461,727	0.1%	2,148,666	3/31/2021
2020 Q4	2/9/2021	539,302	0.1%	2,281,888	12/31/2020
2020 Q3	11/12/2020	706,745	0.2%	2,597,184	9/30/2020
2020 Q2	8/12/2020	728,727	0.2%	2,510,170	6/30/2020
2020 Q1	5/6/2020	593,120	0.2%	2,492,625	3/31/2020
2019 Q4	2/14/2020	549,432	0.1%	2,509,400	12/31/2019
2014 Q1	5/14/2014	205,178	0.1%	2,901,270	3/31/2014
2013 Q4	2/12/2014	208,060	0.1%	2,800,269	12/31/2013